Assessment of cell mediated immunogenicity of Mycobacterium leprae-derived antigens

Cellular Immunology

Volumn 222, Issue 1, 2003, Pages 69-77

  Maeda, Yumi ^a   Gidoh, Masaichi ^a   Ishii, Norihisa ^a   Mukai, Chifumi ^a   Makino, Masahiko ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Antigens; CD4+ T cell; CD8+ T cell; Dendritic cells; IFN ; Mycobacteria; Type 1 cellular immunity

Indexed keywords

BACTERIAL ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN P70;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVITY; CELL MATURATION; CELL MEMBRANE; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSOL; DENDRITE; HUMAN; HUMAN CELL; IMMUNOGENICITY; MYCOBACTERIUM LEPRAE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TUBERCULOID LEPROSY; UPREGULATION;

CORYNEBACTERINEAE; MYCOBACTERIUM LEPRAE;

EID: 0038207032     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(03)00078-9     Document Type: Article

References (45)

1. Stoner G.L. Importance of the neural predilection of Mycobacterium leprae in leprosy. Lancet. 2:1979;994-996.
2. Job C.K. Nerve damage in leprosy. Int. J. Lepr. Other Mycobact. Dis. 57:1989;532-539.
3. Smith W.C. We need to know what is happening to the incidence of leprosy. Lepr. Rev. 68:1997;195-200.
4. World Health Organization (2002) Leprosy-Global situation, in: Wkly. Epidemiol. Rec., 77, 1-8.
5. Maeda S., Matsuoka M., Nakata N., Kai M., Maeda Y., Hashimoto K., Kimura H., Kobayashi K., Kashiwabara Y. Multidrug resistant Mycobacterium leprae from patients with leprosy. Antimicrob. Agents Chemother. 45:2001;3635-3639.
6. Orme I.M., Roberts A.D., Griffin J.P., Abrams J.S. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151:1993;518-525.
7. + T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J. Exp. Med. 187:1998;1633-1640.
8. + CTL specific for the mycobacterial major secreted antigen 85A. J. Immunol. 165:2000;7088-7095.
9. Stenger S., Hanson D.A., Teitelbaum R., Dewan P., Niazi K.R., Froelich C.J., Ganz T., Thoma-Uszynski S., Melian A., Bogdan C., Porcelli S.A., Bloom B.R., Krensky A.M., Modlin R.L. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science. 282:1998;121-125.
10. Thoma-Uszynski S., Stenger S., Modlin R.L. CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis. J. Immunol. 165:2000;5773-5779.
11. Hashimoto K., Maeda Y., Kimura H., Suzuki K., Masuda A., Matsuoka M., Makino M. Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function. Infect. Immun. 70:2002;5167-5176.
12. Inaba K., Metlay J.P., Crowley M.T., Steinman R.M. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172:1990;631-640.
13. Jiao X., Lo-Man R., Guermonprez P., Fiette L., Deriaud E., Burgaud S., Gicquel B., Winter N., Leclerc C. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol. 168:2002;1294-1301.
14. Liu Y.J. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 106:2001;259-262.
15. Thurnher M., Ramoner R., Gastl G., Radmayr C., Bock G., Herold M., Klocker H., Bartsch G. Bacillus Calmette-Guerin mycobacteria stimulate human blood dendritic cells. Int. J. Cancer. 70:1997;128-134.
16. Henderson R.A., Watkins S.C., Flynn J.L. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159:1997;635-643.
17. Modlin R.L., Gebhard J.F., Taylor C.R., Rea T.H. In situ characterization of T lymphocyte subsets in the reactional states of leprosy. Clin. Exp. Immunol. 53:1983;17-24.
18. Sreenivasan P., Misra R.S., Wilfred D., Nath I. Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions. Immunology. 95:1998;529-536.
19. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S.V., Eiglmeier K., Gas S., Barry III C.E., Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Connor R., Davies R., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Barrell B.G.et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 393:1998;537-544.
20. Cole S.T., Eiglmeier K., Parkhill J., James K.D., Thomson N.R., Wheeler P.R., Honore N., Garnier T., Churcher C., Harris D., Mungall K., Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K., Duthoy S., Feltwell T., Fraser A., Hamlin N., Holroyd S., Hornsby T., Jagels K., Lacroix C., Maclean J., Moule S., Murphy L., Oliver K., Quail M.A., Rajandream M.A., Rutherford K.M., Rutter S., Seeger K., Simon S., Simmonds M., Skelton J., Squares R., Squares S., Stevens K., Taylor K., Whitehead S., Woodward J.R., Barrell B.G. Massive gene decay in the leprosy bacillus. Nature. 409:2001;1007-1011.
21. Hunter S.W., Fujiwara T., Brennan P.J. Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae. J. Biol. Chem. 257:1982;15072-15078.
22. Prasad H.K., Mishra R.S., Nath I., Connor R., Davies R., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Barrell B.G.et al. Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type. J. Exp. Med. 165:1987;239-244.
23. Pessolani M.C., Smith D.R., Rivoire B., McCormick J., Hefta S.A., Cole S.T., Brennan P.J. Purification, characterization, gene sequence, and significance of a bacterioferritin from Mycobacterium leprae. J. Exp. Med. 180:1994;319-327.
24. Brennan P.J., Nikaido H. The envelope of mycobacteria. Annu. Rev. Biochem. 64:1995;29-63.
25. Verhagen C., Faber W., Klatser P., Buffing A., Naafs B., Das P., Gillis T.P., Williams D.L. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions. Am. J. Pathol. 154:1999;1793-1804.
26. Hunter S.W., Rivoire B., Mehra V., Bloom B.R., Brennan P.J. The major native proteins of the leprosy bacillus. J. Biol. Chem. 265:1990;14065-14068.
27. Prigozy T.I., Sieling P.A., Clemens D., Stewart P.L., Behar S.M., Porcelli S.A., Brenner M.B., Modlin R.L., Kronenberg M. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity. 6:1997;187-197.
28. Engering A., Geigtenbeek T.B.H., van Kooyk Y. Immune escape through C-type lectins on dendritic cells. Trends Immunol. 23:2002;480-485.
29. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 84:1994;4008-4027.
30. Makino M., Baba M. A cryopreservation method of human peripheral blood mononuclear cells for efficient production of dendritic cells. Scand. J. Immunol. 45:1997;618-622.
31. Makino M., Shimokubo S., Wakamatsu S.I., Izumo S., Baba M. The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. J. Virol. 73:1999;4575-4581.
32. Shepard C.C., McRae D.H. A method for counting acid-fast bacteria. Int. J. Lepr. Other Mycobact. Dis. 36:1968;78-82.
33. Katoch V.M., Katoch K., Ramanathan U., Sharma V.D., Shivannavar C.T., Datta A.K., Bharadwaj V.P. Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining. Int. J. Lepr. Other Mycobact. Dis. 57:1989;615-621.
34. Demangel C., Palendira U., Feng C.G., Heath A.W., Bean A.G., Britton W.J. Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection. Infect. Immun. 69:2001;2456-2461.
35. Ridley D.S., Jopling W.H. Classification of leprosy according to immunity. A five-group system. Int. J. Lepr. Other Mycobact. Dis. 34:1966;255-273.
36. Geijtenbeek T.B.H., van Vliet S.J., Koppel E.A., Sanchez-Hernandez M., Vandenbroucke-Grauls C.M.J.E., Appelmelk B., van Kooyk Y. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197:2003;7-17.
37. Kaufmann S.H.E., Schaible U.E. A dangerous liaison between two major killers: Mycobacterium tuberculosis and HIV target dendritic cells through DC-SIGN. J. Exp. Med. 197:2003;1-5.
38. Salgame P., Abrams J.S., Clayberger C., Goldstein H., Convit J., Modlin R.L., Bloom B.R. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 254:1991;279-282.
39. Dockrell H.M., Young S.K., Britton K., Brennan P.J., Rivoire B., Waters M.F.R., Lucas S.B., Shahid F., Dojki M., Chiang T.J., Ehsan Q., Mcadam K.P.W.J., Hussain R. Induction of Th1 cytokine responses by mycobacterial antigens in leprosy. Infect. Immun. 64:1996;4385-4389.
40. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F., Heath W.R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 393:1998;478-480.
41. Yamauchi P.S., Bleharski J.R., Uyemura K., Kim J., Sieling P.A., Miller A., Brightbill H., Schlienger K., Rea T.H., Modlin R.L. A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy. J. Immunol. 165:2000;1506-1512.
42. + T cells. Nat. Immunol. 2:2001;1010-1017.
43. Ochoa M.T., Stenger S., Sieling P.A., Thoma-Uszynski S., Sabet S., Cho S., Krensky A.M., Rollinghoff M., Nunes Sarno E., Burdick A.E., Rea T.H., Modlin R.L. T-cell release of granulysin contributes to host defense in leprosy. Nat. Med. 7:2001;174-179.
44. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet 348 (1996) 17-24.
45. Langermans J.A., Andersen P., van Soolingen D., Vervenne R.A., Frost P.A., van der Laan T., van Pinxteren L.A., van den Hombergh J., Kroon S., Peekel I., Florquin S., Thomas A.W. Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc. Natl. Acad. Sci. USA. 98:2001;11497-11502.